AZN241129C52000
- 0.00
- 0.000.00%
AstraZeneca Newsroom
AstraZeneca (AZN) Receives a Buy From Goldman Sachs
TRUQAP (Capivasertib) Combination in PTEN-deficient Metastatic Hormone-sensitive Prostate Cancer Demonstrated Statistically Significant and Clinically Meaningful Improvement in Radiographic Progression-free Survival in CAPItello-281 Phase III Trial
AstraZeneca's Truqap Combo Demonstrated Statistically Significant Improvement
GCAR and AstraZeneca Execute Agreement to Evaluate AZD1390 for Glioblastoma
AstraZeneca's Prostate Cancer Treatment Trial Shows Clinically Meaningful Improvement
AstraZeneca (AZN): A Top Pick for Hedge Funds Due to Innovation and Rising Demand
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Trump Nominates Marty Makary For FDA Commissioner
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Top Gap Ups and Downs on Friday: AZN, BABA, PDD and More
European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week
Astrazeneca (AZN.US) and Amgen (AMGN.US) have reported the launch of a subcutaneous injection of TSLP monoclonal antibody in China.
CDE's official website shows that Astrazeneca (AZN.US) and Amgen (AMGN.US) have jointly submitted the application for the listing of TSLP monoclonal antibody Tezepelumab injection.
J.P. Morgan Remains a Buy on AstraZeneca (AZN)
AstraZeneca (AZN) Receives a Buy From Barclays
Amneal Gets FDA Approval for Generic Byetta, Resubmits DHE NDA
Optimism Over Global Healthcare Sector Rises: Jefferies
Unusual Options Activity: APO, CMG and Others Attract Market Bets, APO V/OI Ratio Reaches 359.1
We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative
Discover AstraZeneca's Journey Toward Decision-Centric Autonomous Planning at the Gartner Supply Chain Planning Summit in Denver
CDC Warns Against a Spike in COVID, Flu Cases